Driving and benzodiazepine use - Evidence that they do not mix

被引:29
作者
van Laar, MW [1 ]
Volkerts, ER [1 ]
机构
[1] Univ Utrecht, Fac Pharm, Dept Psychopharmacol, Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands
关键词
D O I
10.2165/00023210-199810050-00007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although the data are sparse, epidemiological studies show that benzodiazepine use increases the relative risk of being involved in a traffic accident by a factor of from 1.5 to about 6.5, depending on dose, number of benzodiazepines used and recency of use. These risks are similar to those associated with blood alcohol concentrations of about 0.6 and 1 g/L, respectively. Experimental studies employing on-the-road driving, driving simulation and laboratory tests measuring skills related to driving have clearly established the dose-dependent performance-impairing effects of benzodiazepines. Benzodiazepine hypnotics vary considerably in their potential to produce residual effects in the morning after nocturnal use. The main determinants of the degree and duration of action after a single dose are size of dose, rate and extent of distribution, lipophilicity and receptor affinity. With repeated administration, compounds with a long elimination half-life (t1/2 beta) are likely to accumulate and produce increased sedation. Diazepam may have a rapid onset of action precipitating the risk of sudden intoxication, but its duration of action is relatively short after a single dose (acute tolerance). The impairing effects of diazepam on driving performance may persist at least during the first 3 weeks of daily administration. The issue of tolerance has not yet been adequately explored and patients should be warned that their performance may not return to the premedication level. Elderly patients may be more sensitive to the sedative and performance-impairing effects than the young, although the evidence is equivocal. Caution is warranted with concomitant use of CNS depressants, such as alcohol, and with drugs interfering with the metabolic pathways of benzodiazepines. Considerable interindividual differences in sensitivity to the behavioural effects of benzodiazepines warrant the careful monitoring of patients. Physicians should educate their patients about the risk of traffic accident during benzodiazepine use.
引用
收藏
页码:383 / 396
页数:14
相关论文
共 79 条
[51]   Considering the P450 cytochrome system as determining combined effects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients [J].
Ramaekers, JG ;
Ansseau, M ;
Muntjewerff, ND ;
Sweens, JP ;
OHanlon, JF .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (03) :159-169
[52]   PSYCHOACTIVE-DRUGS AND THE RISK OF INJURIOUS MOTOR-VEHICLE CRASHES IN ELDERLY DRIVERS [J].
RAY, WA ;
FOUGHT, RL ;
DECKER, MD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (07) :873-883
[53]  
RIEDEL WJ, 1988, 8801 IGVG U LIMB I D
[54]   RESPONSIBILITY ANALYSIS - A METHODOLOGY TO STUDY THE EFFECTS OF DRUGS IN DRIVING [J].
ROBERTSON, MD ;
DRUMMER, OH .
ACCIDENT ANALYSIS AND PREVENTION, 1994, 26 (02) :243-247
[55]  
ROERHS T, 1988, BENZODIAZEPINE RECEP, P194
[56]   DETERMINANTS OF RESIDUAL EFFECTS OF HYPNOTICS [J].
ROTH, T ;
ROEHRS, T .
ACCIDENT ANALYSIS AND PREVENTION, 1985, 17 (04) :291-296
[57]  
ROTHSCHILD AJ, 1992, J CLIN PSYCHIAT, V53, P69
[58]   Acute Behavioral Effects of Triazolam and Caffeine, Alone and in Combination, in Humans [J].
Rush, Craig R. ;
Higgins, Stephen T. ;
Hughes, John R. ;
Bickel, Warren K. .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1994, 2 (03) :211-222
[59]  
SALETU B, 1987, HUMAN PSYCHOPHARMACO, V2, P3
[60]  
SALETU B, 1987, HUM PSYCHOPHARM CLIN, V2, P61